NCT05892146 Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction Status RECRUITING Phase NA
NCT05891821 Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001) Status RECRUITING Phase PHASE2
NCT05878691 A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05873322 Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma Status RECRUITING Phase N/A
NCT05865678 Musculoskeletal Health in Adult Haematological Cancer Survivors Status RECRUITING Phase N/A
NCT05858424 Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer Status RECRUITING Phase NA
NCT05852028 A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma Status UNKNOWN Phase N/A
NCT05834751 the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma Status UNKNOWN Phase NA
NCT05813132 BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation Status COMPLETED Phase NA
NCT05800366 A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma Status RECRUITING Phase PHASE2
NCT05775705 L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH Status NOT_YET_RECRUITING Phase PHASE3
NCT05770037 DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers Status RECRUITING Phase PHASE2/PHASE3
NCT05763563 Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy Status COMPLETED Phase NA
NCT05754814 SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes Status COMPLETED Phase N/A
NCT05751798 Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas Status RECRUITING Phase PHASE1/PHASE2
NCT05745285 Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care Status RECRUITING Phase NA
NCT05737628 First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228 Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05698888 Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors Status TERMINATED Phase PHASE1